MetLife Inc. (NYSE:MET) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 17,980,506 shares, a decline of 15.4% from the October 14th total of 21,245,777 shares. Based on an average trading volume of 5,979,557 shares, the days-to-cover ratio is presently 3.0 days. Currently, 1.9% of the company’s stock are sold short.

In other MetLife news, EVP Frans Hijkoop sold 56,250 shares of MetLife stock in a transaction on Wednesday, November 9th. The shares were sold at an average price of $51.48, for a total transaction of $2,895,750.00. Following the transaction, the executive vice president now directly owns 111,813 shares of the company’s stock, valued at approximately $5,756,133.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Maria R. Morris sold 2,200 shares of MetLife stock in a transaction on Tuesday, November 1st. The stock was sold at an average price of $47.33, for a total transaction of $104,126.00. Following the transaction, the executive vice president now directly owns 109,809 shares in the company, valued at $5,197,259.97. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of MetLife by 2.0% in the second quarter. Vanguard Group Inc. now owns 59,800,082 shares of the company’s stock valued at $2,381,837,000 after buying an additional 1,191,274 shares during the last quarter. Dodge & Cox raised its position in shares of MetLife by 26.4% in the second quarter. Dodge & Cox now owns 39,133,326 shares of the company’s stock valued at $1,558,680,000 after buying an additional 8,185,247 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of MetLife by 10.1% in the second quarter. JPMorgan Chase & Co. now owns 38,433,688 shares of the company’s stock valued at $1,530,815,000 after buying an additional 3,530,969 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of MetLife by 2.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 29,549,210 shares of the company’s stock valued at $1,312,871,000 after buying an additional 604,319 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA raised its position in shares of MetLife by 6.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 28,238,925 shares of the company’s stock valued at $1,124,756,000 after buying an additional 1,684,097 shares during the last quarter. Institutional investors own 73.73% of the company’s stock.

A number of research firms have recently commented on MET. JPMorgan Chase & Co. reiterated a “buy” rating and set a $51.00 target price on shares of MetLife in a research note on Friday, November 4th. Argus set a $54.00 target price on MetLife and gave the stock a “buy” rating in a research note on Friday, October 7th. Deutsche Bank AG reiterated a “hold” rating and set a $44.00 target price on shares of MetLife in a research note on Saturday, October 8th. Bank of America Corp. set a $51.00 target price on MetLife and gave the stock a “buy” rating in a research note on Thursday, October 6th. Finally, TheStreet upgraded MetLife from a “hold” rating to a “buy” rating in a research note on Friday, October 28th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $51.35.

MetLife (NYSE:MET) opened at 54.81 on Friday. MetLife has a one year low of $35.00 and a one year high of $55.30. The stock’s 50 day moving average price is $47.98 and its 200 day moving average price is $43.98. The stock has a market cap of $60.24 billion, a price-to-earnings ratio of 16.84 and a beta of 1.66.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, November 2nd. The company reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.04. The company earned $17.70 billion during the quarter, compared to analyst estimates of $17.03 billion. MetLife had a return on equity of 6.99% and a net margin of 5.58%. The firm’s revenue for the quarter was down 99.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.62 earnings per share. Equities analysts predict that MetLife will post $4.63 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Monday, November 7th will be given a $0.40 dividend. The ex-dividend date is Thursday, November 3rd. This represents a $1.60 annualized dividend and a yield of 2.92%. MetLife’s payout ratio is 49.23%.

About MetLife

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

5 Day Chart for NYSE:MET

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.